ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
药捷安康-B
53.700
-0.050
-0.09%
手动刷新
成交量:
28.16万
成交额:
1,453.86万
市值:
213.13亿
市盈率:
-68.51
高:
54.050
开:
52.750
低:
48.660
收:
53.750
52周最高:
58.050
52周最低:
20.200
股本:
3.97亿
香港流通股本:
3.02亿
量比:
1.47
换手率:
0.09%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.784
净资产收益率:
-41.98%
总资产收益率:
-24.05%
市净率:
37.27
市盈率(LYR):
-68.51
市销率:
- -
数据加载中...
总览
公司
新闻
公告
药捷安康-B(02617.HK)6月13日起招股 发售价将为每股13.15港元
格隆汇
·
06/13
全球首个口服PCSK9抑制剂III期研究成功;药捷安康通过港交所聆讯
氨基观察
·
06/11
《新股》药捷安康通过上市聆讯 去年亏损2.75亿人币
阿斯达克财经
·
06/11
港交所12小时披露5家通过香港上市聆讯,包括曹操出行、圣贝拉、香江电器、颖通控股、药捷安康
港澳IPO上市
·
06/10
新股消息 | 药捷安康通过港交所聆讯 两年累计亏损超6亿元人民币
智通财经
·
06/10
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02617/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":53.7,"timestamp":1756195697357,"preClose":53.75,"halted":0,"volume":281580,"delay":0,"floatShares":301666673,"shares":396897633,"eps":-0.7837992300623309,"marketStatus":"已收盘","change":-0.05,"latestTime":"08-26 16:08:17","open":52.75,"high":54.05,"low":48.66,"amount":14538592,"amplitude":0.100279,"askPrice":53.75,"askSize":500,"bidPrice":53.6,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.7837992300623309,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":53.75,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":1.472606,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-24.05%","roe":"-41.98%","lyrEps":-0.783799,"volumeRatio":1.472606,"shares":396897633,"dividePrice":0,"high":54.05,"amplitude":0.100279,"preClose":53.75,"low":48.66,"week52Low":20.2,"pbRate":"37.27","week52High":58.05,"institutionHeld":0,"latestPrice":53.7,"eps":-0.7837992300623309,"divideRate":0,"volume":281580,"delay":0,"ttmEps":-0.7837992300623309,"open":52.75,"prevYearClose":13.15,"prevWeekClose":54.75,"prevMonthClose":37.95,"prevQuarterClose":30.15,"fiveDayClose":51.7,"twentyDayClose":40.9,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-08-25","current":-71.114754,"percent":0.066667,"low":-72.789898,"twenty":-63.292817,"median":-44.380409,"eighty":-39.630155,"high":-17.403134,"avg":-49.174295,"sd":13.084245,"marketCap":21333247773},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-25","current":-71.114754,"twenty":-63.292817,"median":-44.380409,"eighty":-39.630155,"marketCap":21333247773}],"updateTime":1756186957066},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543523687","title":"药捷安康-B(02617.HK)6月13日起招股 发售价将为每股13.15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543523687","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543523687?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 06:52","pubTimestamp":1749768729,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K1TPS9FM05198ETO.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3638bca7e36188f126db895b5930c5ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K1TPS9FM05198ETO.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02617"],"gpt_icon":0},{"id":"2542998375","title":"全球首个口服PCSK9抑制剂III期研究成功;药捷安康通过港交所聆讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2542998375","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542998375?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 11:28","pubTimestamp":1749612507,"startTime":"0","endTime":"0","summary":"PCSK9赛道风云再起。6月9日,默沙东宣布口服PCSK9抑制剂Enlicitide治疗高胆固醇血症的两项III期研究达到了主要终点。港交所医药企业IPO大年。6月9日,港交所官网显示,药捷安康通过港交所聆讯即将上市,其专注于发现及开发肿瘤、炎症及心脏代谢疾病小分子创新疗法。3)DS-8201新适应症拟优先审评6月10日,据CDE官网,DS-8201新适应症拟优先审评,单药适用于治疗既往接受过一种治疗方案的局部晚期或转移性HER2阳性成人胃或胃食管结合部腺癌患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611113208a703049e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611113208a703049e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226287529.USD","LU0577902611.USD","LU2226246903.HKD","LU1807302812.USD","LU0791591158.USD","LU0348825331.USD","LU0140636845.USD","02617","00388","LU0918141705.HKD","LU1044875133.USD","LU0096374516.USD","LU0607220059.USD","HEXmain","LU0417516902.SGD","LU0577902298.EUR","LU0577902538.SGD","LU0501845795.SGD","LU0211977185.USD","LU0594300179.USD","LU1993786604.SGD","LU2257852520.SGD","LU2449936058.SGD","LU0634319403.HKD","LU0516423091.SGD","LU0605514214.HKD","LU0762542818.HKD","LU0797268264.HKD","LU1734074674.USD","IE00BZ08YS42.EUR","LU1831875114.USD","LU0048580855.USD","LU0516422440.USD","HKXCY","SG9999001846.SGD","LU0594300419.USD","IE00B3T34201.USD","BK1131","LU1642822792.SGD","BK1521","LU0043850808.USD","LU0630378429.USD","LU0898667661.SGD","LU0314109678.HKD","80388","LU0072913022.USD","LU0831103253.SGD","LU1366334578.USD","LU0196878994.USD","IE00BZ08YT58.USD","BK1589"],"gpt_icon":1},{"id":"2542378741","title":"《新股》药捷安康通过上市聆讯 去年亏损2.75亿人币","url":"https://stock-news.laohu8.com/highlight/detail?id=2542378741","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542378741?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 10:33","pubTimestamp":1749609180,"startTime":"0","endTime":"0","summary":"药捷安康通过港交所上市聆讯,将在上市。招股书披露,公司是以临床需求为导向、处于注册临床阶段的生物制药公司,专注于发现及开发肿瘤、炎症及心脏代谢疾病小分子创新疗法。资料显示,药捷安康2023年收入118.1万元人民币(下同),而2024年无录得营收;研发成本分别为3.45亿及2.44亿元;期内分别亏损3.43亿及2.75亿元。沽空资料截至 2025-06-10 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191017105308849_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191017105308849_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1445969/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1282649067.USD","SG9999001093.SGD","LU1813983027.USD","BK1589","LU2257852520.SGD","LU0140636845.USD","LU0577902454.USD","LU0348816934.USD","LU0605514214.HKD","IE00B3T34201.USD","80388","LU2449936058.SGD","LU0918141705.HKD","LU0577902538.SGD","LU0516423091.SGD","02617","HKXCY","LU0572944931.SGD","LU0197773160.USD","LU0488056044.USD","SG9999002463.SGD","LU1993786604.SGD","LU0577902298.EUR","LU0648948544.HKD","LU0261947096.USD","LU0516422440.USD","LU0630378692.HKD","LU1807302812.USD","LU1366334651.USD","LU1044875133.USD","LU0061477393.USD","LU1105468828.SGD","LU0072913022.USD","LU0096374516.USD","LU1831875114.USD","LU0417516738.SGD","LU0348735423.USD","LU0384037296.USD","LU0048597586.USD","LU0501845795.SGD","BK1521","LU0348825331.USD","LU1044874839.SGD","LU0516422952.EUR","BK1131","LU0196878994.USD","HEXmain","LU0197773673.USD","LU0048580855.USD","LU2226246903.HKD"],"gpt_icon":1},{"id":"2542343558","title":"港交所12小时披露5家通过香港上市聆讯,包括曹操出行、圣贝拉、香江电器、颖通控股、药捷安康","url":"https://stock-news.laohu8.com/highlight/detail?id=2542343558","media":"港澳IPO上市","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542343558?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 14:15","pubTimestamp":1749536100,"startTime":"0","endTime":"0","summary":"港交所官网于昨晚至今早在不到12个小时的时间披露了5家拟上市公司通过港交所上市聆讯,分别是:来自江苏苏州的中国第二大网约车平台 -曹操出行;来自湖北黄冈的中国第十大厨房小家电企业 -香江电器;来自浙江杭州的母婴护理平台 -圣贝拉Saint Bella;来自香港的香水品牌管理公司 -颖通控股Eternal Beauty;来自江苏南京的未盈利生物科技公司 -药捷安康-B。部分文章推送时未能与原作者或公众号平台取得联系。若涉及版权问题,敬请原作者联系我们。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI1NTA3NDA2MA==&mid=2247502148&idx=3&sn=dba48a75912db4fec3face1d16db3198&chksm=eb93823b496a1d6d58238f702a9dfa1b8ab8bc859d7ed4df8dafd3677a5dfe6814864606b27a&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["06883","02619","02643","02617"],"gpt_icon":1},{"id":"2542735596","title":"新股消息 | 药捷安康通过港交所聆讯 两年累计亏损超6亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2542735596","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542735596?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 07:08","pubTimestamp":1749510501,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1303212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":65,"code":"91000000","status":"200"}]}}